Longtime senior executive, Anthony W. Deering has held leadership roles in a number of large publicly listed companies. Currently the Chairman of the private investment firm Exeter Capital, LLC, Anthony W. Deering also holds a number of directorships, including the role of Lead Independent Director of T. Rowe Price mutual funds.
Based in Baltimore, Maryland, the global investment management firm T. Rowe Price held assets under management valued at $903.6 billion, as of June 30, 2017. Part of Fortune magazine’s 2017 list of the World’s Most Admired Companies, the firm offers low-cost mutual funds, with more than 75 percent of its individual investors’ designated funds having expense ratios lower than their peer category averages.
Many of T. Rowe Price’s mutual funds are acknowledged with top ratings from leading independent research firm Morningstar. As of May 31, 2017, more than 70 of T. Row Price’s funds have received overall Morningstar ratings of four stars or five stars, with five stars standing as the highest rating.
Only 32.5 percent of all funds receive a four- or five-star rating from Morningstar. It should be noted that previous performance cannot guarantee future outcomes.
With more than 40 years of senior executive experience, Anthony W. Deering has served in management positions for several large companies throughout the United States. Anthony W. Deering has also been a board member of a number of organizations and charities. His service includes a term as chairman of the board for the Baltimore Museum of Art.
Opened in 1914, the Baltimore Museum of Art features 210,000 square feet of exhibition space within a historic 1920s building designed by architect John Russell Pope. The museum includes over 95,000 artifacts and works from around the world, many of which were featured in the Art of the Ancient Americas exhibit.
Dating back to 2500 BC, Art of the Ancient Americas highlighted works from native cultures such as the Chimu and Muisca people of Andean South America and the Aztec and Maya people of Mesoamerica. One of the original exhibits in this collection included the Myths of Ancient Peru, a collection of Peruvian ceramics. Other important objects included figures depicting Maya and Aztec noblewomen, and a serpentine figure of Olmec origin.
Before becoming the chairman of Exeter Capital in Lutherville, Maryland, Anthony W. Deering attended the University of Pennsylvania Wharton School of Business where he earned an MBA. Anthony W. Deering also received an honorary doctor of humane letters in 2015 from Johns Hopkins University in Baltimore, Maryland.
A preeminent educational institution, Johns Hopkins University was established more than 140 years ago and currently includes training activities and research centers in over 150 countries around the world. The university features nine different academic divisions, including the Carey Business School.
Founded in 2006, the Carey Business School was named after William Polk Carey, an American businessman and philanthropist. It offers research programs that study the effects of business in government and the challenges posed by government regulations and initiatives. As a part of its student training in meeting business challenges, the school has created student initiatives like the Innovation for Humanity project.
The Innovation for Humanity experience is an international program that helps students become more creative business leaders and learn how to build sustainable businesses. The program includes a three-week residency along with traveling to various sites to study global challenges regarding social welfare, deteriorating infrastructure, and public health issues.
An accomplished businessman, Anthony W. Deering, has served as Chairman of Exeter Capital, LLC, a private investment firm, since 2004. Alongside his responsibilities with Exeter Capital, Anthony W. Deering is a Director of Under Armour, a leading producer of athletic clothing based in Baltimore. To give back to the communities it serves, Under Armour has undertaken a number of philanthropic initiatives, including WIN Global.
WIN Global aims to empower the next generation of athletes by connecting children in underserved communities to opportunities for playing and practicing sports. To accomplish this mission, WIN Global has undertaken a range of projects, such as improvements to playground areas and the creation of initiatives that teach life skills through sports-driven lessons. In addition, it invests in equipment for participating children and provides support to coaches and other individuals who dedicate their lives to uplifting these communities.
As the name of the program implies, WIN Global seeks to empower communities around the world, and it invites organizations from the communities it serves to apply for grants to further its mission. More information is available online at UnderArmour.com.
Since 2004, Anthony W. Deering has headed the private investment firm Exeter Capital, LLC, as Chairman. Outside of work, Anthony W. Deering contributes to organizations such as Johns Hopkins Medicine (JHM), where he serves as a Trustee. As one of the nation’s leading health care organizations, JHM undertakes research in a wide range of areas to improve disease prevention and care processes.
Recently, Hopkins researchers looked at nearly 1,500 adult patients who were given antibiotics while in the hospital. The researchers discovered that about a fifth of the cases resulted in undesirable side effects, and about a fifth of those involved patients who did not in fact need antibiotics. More research is emerging about the potential harm of antibiotics, and this new study, published in JAMA Internal Medicine, affirms the findings. Ultimately, researchers want to encourage physicians to consider both risks and benefits before prescribing antibiotics.
The most common side effects of antibiotic use observed in the study included gastrointestinal distress, kidney problems, and blood abnormalities. Patients also experienced new multi-drug-resistant infections and development of a bacterium linked to severe diarrhea. While these side effects did not lead to death in any cases, they led to extended hospital stays, caused hospital readmissions, and necessitated additional diagnostics.
A graduate of the Wharton School of Business, Anthony W. Deering has established his career in the finance and real estate industries, and he has amassed several years of board experience with such entities as Deutsche Bank, T. Rowe Price, and Alex Brown Realty. Most recently, Anthony W. Deering has served as the Chairman of Exeter Capital, LLC.
In the business world, various researchers and analysts have observed patterns in how companies fill the roles of chairman and CEO. Some organizations operate with one individual fulfilling each position while others employ two separate executives. According to a recent Harvard Law School study, the latter scenario, with two separate roles, is becoming more commonplace.
The study included an analysis of companies on the 2016 Fortune 1000 list. From the results, the team concluded that whereas smaller businesses designate one professional to fulfill the combined duties, larger companies favor filling the chairman and CEO positions with two different leaders. A similar survey of the S&P 500 Index revealed that dual chairman/CEOs lead roughly half of the organizations, compared to 77 percent in the early 2000s.
Although separating the roles appears to be a growing trend, advantages and disadvantages still exist for both approaches. Board members, who elect the chairman, must ultimately decide how to structure these leadership positions to the maximum benefit of their operations.
After a successful career with The Rouse Company, where he served as CEO for seven years, Anthony W. Deering is now the chairman of Exeter Capital, LLC, a position he has held since 2004. Anthony W. Deering also sits on the board of directors for Brixmor Property Group and apparel manufacturer Under Armour.
One of the most prominent athletes linked to Under Armour is Golden State Warriors guard and two-time NBA Most Valuable Player, Stephen Curry. Under Armour signed the NBA superstar to an endorsement deal in 2013 and extended the contract through to 2024 after Curry’s banner seasons in 2014 and 2015. To date, Curry’s name has been associated with more than 100 shoe designs for the company.
A recent Curry signature shoe – the Curry 3 Grey Matter – was released in late 2016. The shoe features Under Armour’s patented Threadborne technology, comprised of more durable yarns that are turned into fabric designed to hold up throughout the course of a basketball season. Grey in color, the shoes also promise a solid structure and proper support, with cushioning made to absorb the impacts specific to basketball.